In her blog, focused on opioid addiction and its treatment with medication, Dr. Jana Burson discusses the potential benefits of CAM2038, a new preparation of buprenorphine that can be given in a subcutaneous injection weekly or monthly. If it works as well or better than sublingual buprenorphine, she believes it could be the solution to some difficult problems including, time commitments, diversion, travel challenges and others.
AMA 2025 Report on Substance Use and Treatment Sees Drop in Overdose Deaths, Calls on Policymakers to Remove Obstacles to Evidence-based Care
The American Medical Association’s 2025 Report on Substance Use and Treatment notes a decline in overdose deaths while...



0 Comments